Introduction
============

The use of allograft tissue for anterior cruciate ligament (ACL) reconstruction has been popularized in the last two decades. Its increased availability, in addition to the numerous advantages like extreme versatility, possibility of bone grafting, and no donor site morbidity, made the allograft tissue an appealing alternative to autograft for primary ACL reconstruction and especially for ACL revision. The American Association of Tissue Banks reports that the demand for musculoskeletal grafts has grown from nearly 700,000 grafts in 2001 to approximately 1.5 million distributed in 2007, while the American Academy of Orthopaedic Surgeons has estimated that approximately 60,000 allografts were used in knee reconstruction procedures alone in 2005. [@JR1700013-1] [@BR1700013-2] Furthermore, the multicentric ACL revision study reported that allografts were used in 27% of primary ACL reconstruction and in 54% of ACL revision. [@JR1700013-3] Despite good results have been reported in both these circumstances, [@JR1700013-4] [@JR1700013-5] [@JR1700013-6] [@JR1700013-7] [@JR1700013-8] the use of allograft is believed to produce inferior outcomes compared with autograft [@JR1700013-9] probably due to the slower incorporation process, [@JR1700013-10] [@JR1700013-11] [@JR1700013-12] the risk of disease transmission and immunological reaction, [@JR1700013-13] [@JR1700013-14] and the compromised biomechanical proprieties related to sterilization process. [@JR1700013-15]

However, there are numerous variables like graft type, mechanical properties, surgical technique, sterilization method, follow-up, and patients characteristics, which could influence the results after ACL reconstruction with allograft. [@JR1700013-16] [@JR1700013-17] [@JR1700013-18] [@JR1700013-19] Regarding the age of graft donor, some advocate choosing tissue from younger donors on the premise that younger donors will have stronger tissue and, therefore, improved clinical results; however, controversies remain on this issue, due to the few discordant evidences from both in vitro and in vivo studies. [@JR1700013-20] [@JR1700013-21] [@JR1700013-22] [@JR1700013-23] [@JR1700013-24] [@JR1700013-25]

The purpose of the present study was to investigate risk factors that could influences mid-term clinical results of revision ACL using nonirradiated Achilles tendon allograft, particularly the allograft donor age. The hypothesis was that higher age of graft donor was associated with worse subjective clinical results, after double-bundle ACL revision with nonirradiated Achilles tendon allograft.

Methods
=======

All patients that underwent revision ACL between 2004 and 2008 were included in the study. Inclusion criteria were isolated or combined revision ACL with Achilles tendon allograft, age \>18 years, no knee malalignment or knee malalignment corrected at time of indexed surgery or within 6 months from the indexed surgery. Exclusion criteria were follow-up \< 4 years and contralateral unstable or operated knee. For all the patients that met the inclusion criteria, the age of the graft donor was obtained from the tissue bank.

The patients that presented all the required characteristics to be involved in the study were contacted by phone by one investigator, which administered the Lysholm score. The Lysholm score is a patient-reported clinical score composed by eight multiple-answer questions that evaluate the limping due to knee pathologies, swelling, pain, instability, locking and giving-way sensation. [@JR1700013-26] The score ranges from 0 to 100, where 0 represents complete disability and 100 represents optimal knee function. The Lysholm score was administered both at final follow-up and at preoperative status based on patient recall. All the data regarding age at primary reconstruction, age at revision, age at final follow-up, time from primary reconstruction to revision surgery, meniscal status, final follow-up, more than one prior ACL reconstruction, and combined procedures (excluding meniscectomy) were collected as well from the medical charts.

Patients were divided in two groups based on the donor age. Since Swank et al [@JR1700013-25] reported a decrease in ultimate tensile strength of allograft after the age ranging from 40 to 50 years, the mean value of this range (45 years) was chosen as cut-off value (\< 45 years vs ≥ 45 years).

Allograft Handling and Surgical Technique
-----------------------------------------

All patients were operated using a nonanatomical double-bundle technique with nonirradiated Achilles tendon allograft. [@JR1700013-27] All the grafts were obtained from a single certified tissue bank (Banca delle cellule e del tessuto muscoloscheletrico, Bologna, Italy). The grafts were harvested in sterile fashion by four orthopedic surgeons and residents. At the end of the harvesting, before cadaver reconstruction, swabs for microbiological tests were obtained. Grafts were, therefore, stored at -80°C until the date of the planned surgery, without undergoing gamma irradiation. In the operating room, the grafts were defrosted with hot water 30 minutes before the beginning of the surgical procedure, and further swabs were obtained. The grafts were then split in a "Y" shape, with the vertex separated from the calcaneal bone, which was eventually used for tunnel bone grafting. A 10-mm tunnel was drilled through the tibia directed to the posteromedial part of the ACL footprint and a 7-mm tunnel was drilled from the anteromedial portal through the medial wall of the femoral condyle. After a lateral 3 to 5 cm incision to reach the posterior aspect of the capsule, both bundles of the graft were passed in the tibial tunnel, then one in the over-the-top position and one through the femoral tunnel. Finally, both were fixed to the femoral and tibial cortex with barbed metal staples.

All patients followed the same rehabilitation protocol, with return to unrestricted activity at 6 to 9 months.

Statistical Analysis
--------------------

Statistical evaluation was performed using MedCalc (MedCalc software, Acacialaan 22, Ostend, Belgium). All the parametric continuous data were expressed as mean ± standard deviation. The categorical data were expressed as absolute number and percentage. After the data have been tested for normal distribution, paired *t* -test was used to compare preoperative and postoperative values of Lysholm score. Chi-square was used to compare categorical variables.

Multiple regression analysis was performed using postoperative Lysholm score and as main outcomes. The regression analyses were performed in a stepwise fashion. Independent variables considered were age at primary reconstruction, age at revision, age at final follow-up, time from primary reconstruction to revision surgery, meniscus deficiency, final follow-up, more than one prior ACL reconstruction, combined procedures (except meniscectomy), preoperative Lysholm score, and graft donor age. Level of significance was set with *p*  \< 0.05.

A posthoc power analysis was performed using means and standard deviations of the postoperative Lysholm score of the two groups based on allograft donor age \< 45 or \> 45 years. The *α* value was set at 0.05 and the power was calculated.

Results
=======

Overall, 84 patients underwent revision ACL reconstruction in the considered time period. Eleven patients were excluded because a different graft was used, seven patients had previous contralateral ACL reconstruction, four patients were \< 18 years old at time of revision, and two patients did not reach the minimum follow-up of 4 years. Of the 60 eligible patients, eight (13%) patients were lost to follow-up. Therefore, the patients available at a mean 4.8 ± 0.8 years follow-up were 52 ( [Table 1](#TB1700013-1){ref-type="table"} ). Statistical analysis showed a significant improvement in the Lysholm score from 62.3 ± 6.6 at preoperative status to 84.4 ± 12.3 at final follow-up. The mean donor age was 48.7 ± 8.4 years; 14 patients (27%) received a graft with an age \< 45 years, while 38 patients (73%) received a graft with an age ≥ 45 years. Baseline characteristics between the two groups were similar; however, the Lysholm at final follow-up was significantly higher in patients who received a younger allograft ( *p*  = 0.0469) ( [Table 2](#TB1700013-2){ref-type="table"} ).

###### Demographic and surgical details of the 52 patients included in the study

  Variables                               Mean    SD          Range
  --------------------------------------- ------- ----------- --------
  Age at primary ACL reconstruction (y)   23.5    6.7         14--45
  Age at ACL revision (y)                 28.6    7.8         19--47
  Age at follow-up (y)                    33.3    7.7         23--50
  Time from primary ACL to revision (y)   5.0     4.2         1--21
  Follow-up (y)                           4.8     0.8         4--7.6
  Allograft donor age (y)                 48.7    8.4         29--62
  Sex (male/female)                       48/4    (92%/8%)    
  Side (right/left)                       28/24   (54%/46%)   
  Meniscal status (intact/deficient)      18/34   (35%/65%)   
  Combined procedure (yes/no)             10/42   (19%/81%)   
  Multiple revision (yes/no)              8/44    (15%/85%)   

Abbreviations: ACL, anterior cruciate ligament, SD, standard deviation,

Note: Data are expressed as mean, SD, and range (ACL).

###### Comparison of demographic, surgical, and clinical details of the two subgroups of patients based on the allografts donor age (\<45 y vs. ≥ 45 y)

  Variables                               \<45 y ( *n*  = 14)   ≥45 y ( *n*  = 38)   *p* -Value           
  --------------------------------------- --------------------- -------------------- ------------ ------- -------------------------------------------------
  Allograft donor age (y)                 38.1                  ±5.9                 52.6         ±5.2    \<0.0001 [a](#FN1700013-5){ref-type="table-fn"}
  Age at primary ACL reconstruction (y)   23.4                  ±7.3                 23.6         ±6.7    =0.9340
  Age at ACL revision (y)                 29.6                  ±9.1                 28.2         ±7.5    =0.6946
  Age at follow-up (y)                    33.8                  ±9.1                 33.2         ±7.4    =0.8457
  Time from primary ACL to revision (y)   6.2                   ±7.1                 4.6          ±2.6    =0.1750
  Follow-up (y)                           4.4                   ±0.4                 5.0          ±1.1    =0.3941
  Sex (male/female)                       12/2                  36/2                 =0.6199              
  Side (right/left)                       8/6                   20/18                =0.7719              
  Meniscal status (intact/deficient)      3/11                  15/23                =0.2250              
  Combined procedure (yes/no)             1/13                  9/29                 =0.1794              
  Multiple revision (yes/no)              3/11                  5/33                 =0.4632              
  Preoperative Lysholm score              62.4                  ±4.3                 62.3         ±7.3    =0.6523
  Postoperative Lysholm score             89.5                  ±3.2                 80.1         ±11.1   =0.0469 [a](#FN1700013-5){ref-type="table-fn"}

Abbreviations: ACL, anterior cruciate ligament, SD, standard deviation,

Note: Data are expressed as mean, SD and *p* -Values (ACL).

Statistically significant values ( *p*  \< 0.05).

The multiple regression model showed the graft\'s donor age ( [Fig. 1A](#FI1700013-1){ref-type="fig"} ), the follow-up length ( [Fig. 1B](#FI1700013-1){ref-type="fig"} ), and the preoperative Lysholm score ( [Fig. 1C](#FI1700013-1){ref-type="fig"} ) as a significant predictor of postoperative Lysholm score ( [Table 3](#TB1700013-3){ref-type="table"} ). Specifically, the value seemed to decrease approximately 5 points every 10 years of donor age increase. Regarding follow-up, the postoperative Lysholm value seemed to decrease approximately 5 points every 1 year after revision surgery. In addition, the preoperative Lysholm score influenced almost 1.5 points of the postoperative value. The regression model was statistically significant ( *p*  \< 0.05).

###### Multiple regression analysis: a coefficient \<0 or \>0 indicates respectively a negative or positive correlation of the variable with the main outcome

  Independent variables        Coefficient   SD       *r* ~partial~   *p* -Value
  ---------------------------- ------------- -------- --------------- ------------
  Allograft donor age          --0.546       0.2031   --0.4972        0.0134
  Follow-up                    --4.7205      2.1264   --0.4278        0.037
  Preoperative Lysholm score   1.5263        0.3545   0.6763          0.0003

Abbreviations: *r* ~partial~ , coefficient of correlation of the variable adjusted for the effect of the other variables in the model; SD, standard error.

Note: Significance level: *p*  = 0.0002.

![Scatter plots graphics of the distribution of the postoperative Lysholm scores (y-axis) based on donor age ( **A** ), follow-up ( **B** ), and preoperative Lysholm score ( **C** ) at x-axis. The dotted line represents the tendency line.](10-1055-s-0038-1626739-i1700013-1){#FI1700013-1}

Posthoc power analysis for the postoperative Lysholm score showed a power of 99.7%.

Discussion
==========

The most important finding of the present study is that higher age of graft donor is associated with worse subjective clinical results at mid-term, after double-bundle ACL revision with nonirradiated Achilles tendon allograft. Furthermore, the length of the follow-up and the preoperative clinical status seemed to influence the postoperative results as well. However, the improvement in knee function did not substantially differ from what reported in other clinical studies. Pascual-Garrido et al [@JR1700013-28] reported an improvement of approximately 30 points of Lysholm scores using both nonirradiated patellar tendon and anterior tibialis at 2 to 4 years follow-up. The inferior improvement reported in the present study (22 points) could reflect the longer follow-up, as the multivariate analysis identified the follow-up as a variable that could influence negatively the clinical outcomes. Moreover, also the high number of meniscal lesions and combined procedure, summed to the presence of several multiple revisions, could have contributed.

The impact of donor age in ACL reconstruction with allografts still represents a controversial topic. Previous studies demonstrated the age-related decline in the biomechanical proprieties of the human ACL in the function of age. [@JR1700013-29] [@JR1700013-30] Conversely, the structural proprieties were reported to be independent from donor age for fresh-frozen bone-patellar-tendon-bone [@JR1700013-20] [@JR1700013-21] and anterior and posterior tibialis allograft. [@JR1700013-22] [@JR1700013-25] However, it should be remarked that only two studies [@JR1700013-24] [@JR1700013-25] included donors older than 55 years, thus limiting the potential negative effects of tendon aging. Differently, Lewis and Shaw [@JR1700013-24] reported an age-related effect on the ultimate tensile strength, linear stiffness, and tangent modulus of human Achilles tendon allografts, thus recommending that when the allograft option is to be followed, Achilles tendon from young donors should be used whenever possible for the repair of the severely damaged tendon or ACL. This age-related Achilles tendon allograft behavior could be due to a different tissue quality according to donor age, as it has been demonstrated that Achilles tendon undergoes substantial aging-induced changes that negatively affect the mechanical proprieties of in vivo tendon. [@JR1700013-31]

Regarding clinical results, Hampton et al [@JR1700013-23] showed no influence of patellar-tendon allograft donor age, while the present study involving Achilles tendon allograft showed a decrease in clinical outcomes as donor age rises. This difference could be both due to the allograft tissue itself and to the fact that all the patients involved in the present study underwent revision ACL, while the cohort of Hampton et al [@JR1700013-23] involved only primary isolated ACL reconstruction. It is reasonable that in patients with failed ACL reconstruction, the secondary stabilizer structures could have suffered higher damage than after primary ACL injury, thus placing more importance on the quality of the graft used to restore knee stability. Moreover, Hampton et al [@JR1700013-23] utilized both nonirradiated and low-dose irradiated allografts. The effects of irradiation (up to 28 kGy) have been in fact demonstrated to alter the structural and mechanical proprieties of the grafts, [@JR1700013-32] even if the use of low-dose irradiation seemed to mitigate such effect. [@JR1700013-22] However, Grassi et al [@JR1700013-17] in their meta-analysis of 32 studies, regarding ACL revision, found out that outcomes between autografts and allografts were similar if studies regarding irradiated allografts (2 studies) were excluded.

Also, the type of graft and its biomechanical characteristics should not be ignored when comparing results of ACL reconstruction with allografts. It was in fact reported that the medial half of Achilles tendon allograft presents a lower failure load compared with anterior tibialis, posterior tibialis, peroneus longus, and hamstrings. [@JR1700013-33] It is reasonable that, however, often exceeding the strength of native ACL, the strength of the allograft tissue decreases due to the avascular necrosis that occurs during healing and incorporation process, making sometimes the in vitro load to failure a misleading parameter to predict the in vivo behavior of the graft. In this regard, also the bone-to-bone or soft-tissue-to-bone healing, and the graft manipulation or configuration (thick single-bundle vs. splitted double bundle) could play a non-negligible role. Therefore, unless well-designed controlled studies comparing Achilles tendon and other graft types, no conclusions can be drawn regarding the effect of donor age on clinical results according to graft type.

Lastly, it should be mentioned that also the preoperative patient status and knee function could influence the outcome; specifically, patients with less disability were more likely to present final higher functional scores after ACL revision. It should be acknowledged that the nine-point difference found between patients that received younger or older allograft could represent a borderline value for clinical significance, as the minimum clinically important difference for Lysholm score has not been determined. [@JR1700013-34]

The present study presents several limitations: the limited number of patients could have failed to detect significant findings regarding the less represented variables, like combined procedures and multiple revisions. In addition, the Lysholm score has not yet been validated in Italian language and being a patient-reported clinical score, language comprehension could represent a bias in score evaluation. However, the main strength of the present study is represented by the fact that all ACL revision were performed with the same technique by the two senior surgeons using allograft tissue provided by a single certified tissue bank, thus receiving the same handling process.

In conclusion, the age of allograft donor, length of follow-up, and preoperative clinical status seem to be predictors of mid-term results after revision ACL with nonirradiated Achilles tendon allograft. Especially, as older graft donor was a negative predictor for final functional outcomes, when using Achilles tendon allografts, young donors should be used for the present double-bundle revision ACL reconstruction.
